Skip to main content
Clinical Trials/NCT04000659
NCT04000659
Active, Not Recruiting
N/A

A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Episealer® Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions

Episurf Medical Inc.13 sites in 4 countries13 target enrollmentJune 18, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Degenerative Lesion of Articular Cartilage of Knee
Sponsor
Episurf Medical Inc.
Enrollment
13
Locations
13
Primary Endpoint
Incidence of subsidence or migration at 24 months
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

The study is a randomized, prospective, multicenter, controlled clinical trial of the Episealer Knee System. The Episealer Knee System is intended for subjects with up to two focal femoral knee chondral or osteochondral lesion that is causing pain and/or disability and requires surgical treatment.

Detailed Description

The primary objective of this study is to evaluate the safety and clinical effectiveness of the Episealer Knee System (Episealer Trochlea Solo, Episealer Femoral Twin, and Episealer Condyle Solo) compared to microfracture (with or without debridement) in a group of subjects that require repair of up to 2 focal femoral chondral or osteochondral lesions in the knee. Clinical success will be analyzed via subject reported outcomes to measure function and pain improvements as compared to baseline, incidence of secondary surgical interventions for the treated knee, absence of subsidence or migration through radiographic assessment, and assessment of weight-bearing status.

Registry
clinicaltrials.gov
Start Date
June 18, 2020
End Date
June 2028
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of subsidence or migration at 24 months

Time Frame: 24 Months

This endpoint will examine the incidence of subsidence/migration at 24 months

Incidence of Secondary Surgical Intervention

Time Frame: 24 Months

This endpoint will examine the incidence of Secondary Surgical Interventions (SSIs) at 24 months

Change in Visual Analog Scale (VAS) Pain Scores

Time Frame: 24 Months

This endpoint will examine the change in VAS Pain scores at 24 months

Change in the Knee Injury & Osteoarthritis Outcome Score (KOOS) Subscores

Time Frame: 24 Months

This endpoint will examine the change in KOOS subscores at 24 months

Weight bearing status

Time Frame: 8 weeks

This endpoint will examine the weight bearing status at 8 weeks

Secondary Outcomes

  • Change in 12-Item Short Form Survey (SF-12) score at all follow-up time points(3-weeks, 8-weeks, 6-months, 12-months, and 24-months)
  • Change in VAS Pain score at all follow-up time points(3-weeks, 8-weeks, 6-months, 12-months, and 24-months)
  • Incidence of adverse events and device deficiencies at all follow-up time points(3-weeks, 8-weeks, 6-months, 12-months and 24-months)
  • Incidence of radiographic findings at all follow-up time points(8 weeks, 12-months, and 24-months)
  • Change in the KOOS Subscores at all follow-up time points(3-weeks, 8-weeks, 6-months, 12-months, and 24-months)

Study Sites (13)

Loading locations...

Similar Trials